Contracts › 75F40126C00085

75F40126C00085: The Proposed Baa Research Will Provide Critical Developments in Lyophilization Techniques for Pharmaceuticals and Biologics, Which Will in Turn Support Efficiencies in Assessment of New Biologics and Biosimilars, and the Domestic Manufacturing of Bio

Awarded to Purdue University by Food and Drug Administration (FDA).

$1.4Mobligated

$1.4Mpotential value

29 September 2028current end date

See modifications, all subcontractors and funding in FedSift →

Contract	75F40126C00085
Awardee	Purdue University
Awarding agency	Food and Drug Administration (FDA)
Awarding office	FDA OFFICE OF ACQ GRANT SVCS
NAICS	611310 Colleges, Universities, and Professional Schools
PSC	R499 Support- Professional: Other
Place of performance	IN
Offers received	1
Period of performance	01 September 2026 to 29 September 2028
Potential end	29 September 2028
Estimated recompete solicitation	~Q2 2028 (estimate, ~6 months before expiry)

Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 12 October 2026. The solicitation date is an estimate from the end date, not a posted date.